Destiny Pharma
21 Podcast Episodes
1574: Vadim Alexandre discusses Spectral MD, Lunglife AI & Destiny Pharma
1574: Vadim Alexandre discusses Spectral MD, Lunglife AI & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel discusses: Spectral MD #SMD Lunglife AI #LLAI Destiny Pharma #DEST
10 Aug 2023
•
26mins
1552: Alan Green talks about: Destiny Pharma, ECR, Acuity, First Class Metals & Truspine
1552: Alan Green talks about: Destiny Pharma, ECR, Acuity, First Class Metals & Truspine
Alan Green, CEO of Brand Communications talks about the following companies: Destiny Pharma #DEST ECR Minerals #ECR ... Read more
25 Jul 2023
•
30mins
Similar People
Bill Brodie Good
Craig Martin
Mike Ralston
Nick Lee
Taylor Wimpey
Philip Haydn-Slater
Majid Shafiq
Graham Heath
John Meyer
Polarean Imaging
Dan Lane
Cathal Friel
Gil Holzman
Glen Goodman
Charles Bray
1523: Vadim Alexandre on Asos, Boohoo, AO World, Deliveroo, Novacyt, YourGene & Destiny Pharma
1523: Vadim Alexandre on Asos, Boohoo, AO World, Deliveroo, Novacyt, YourGene & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel covers some retail stocks and news from medical diagnostics & biotec... Read more
6 Jul 2023
•
27mins
1380: Neil Clark of Destiny Pharma: SPOR-COV® research reveals very exciting data and sets up potential royalty payments
1380: Neil Clark of Destiny Pharma: SPOR-COV® research reveals very exciting data and sets up potential royalty payments
Neil Clark, CEO of Destiny Pharma #DEST describes how SPOR-COV® showed positive results from testing in several COVID-19... Read more
2 May 2023
•
12mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
1370: Vadim Alexandre discusses Polarean Imaging & Destiny Pharma
1370: Vadim Alexandre discusses Polarean Imaging & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel talks about the following companies: Polarean Imaging #POLX & Destin... Read more
27 Apr 2023
•
26mins
1327: Neil Clark of Destiny Pharma: Our number one target is a deal on XF-73 this year
1327: Neil Clark of Destiny Pharma: Our number one target is a deal on XF-73 this year
Neil Clark, CEO & Shaun Claydon, CFO of Destiny Pharma #DEST discuss their final results & post period highlight... Read more
13 Apr 2023
•
16mins
1301: Neil Clark of Destiny Pharma discusses XF-73’s significant Phase 2 data published in a peer reviewed journal & potential upside
1301: Neil Clark of Destiny Pharma discusses XF-73’s significant Phase 2 data published in a peer reviewed journal & potential upside
Neil Clark, CEO of Destiny Pharma #DEST discusses XF-73’s Phase 2 data published in peer reviewed journal and the potent... Read more
24 Mar 2023
•
17mins
1211: Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to $570m plus royalties
1211: Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to $570m plus royalties
Neil Clark, CEO & Shaun Claydon CFO of Destiny Pharma #DEST discuss their exclusive collaboration and co-development... Read more
24 Feb 2023
•
8mins
883: Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond
883: Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond
Neil Clark CEO & Shaun Claydon, CFO of Destiny Pharma #DEST & reflect on the progress they have made on their la... Read more
8 Sep 2022
•
8mins
814: Neil Clark, CEO of Destiny Pharma, explains the significance of new data for NTCD-M3, its novel treatment for C. difficile infection
814: Neil Clark, CEO of Destiny Pharma, explains the significance of new data for NTCD-M3, its novel treatment for C. difficile infection
Destiny Pharma #DEST chief executive Neil Clark talks us through the publication of new data on NTCD-M3, its novel treat... Read more
26 Jul 2022
•
8mins
